Effectiveness of lomustine and bevacizumab in progressive glioblastoma: a meta-analysis

BACKGROUND: Glioblastomas (GBMs) are the most aggressive type of glial brain tumors. Despite aggressive treatment with surgery and chemoradiation, GBMs invariably relapse and tumors are progressive. Controversy remains on optimal treatment of patients with recurrent GBMs. Data from previous trials h...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jie, Xue, Yue-Qin, Zhao, Ming-Ming, Xu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005326/
https://www.ncbi.nlm.nih.gov/pubmed/29942135
http://dx.doi.org/10.2147/OTT.S160685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005326/
https://www.ncbi.nlm.nih.gov/pubmed/29942135
http://dx.doi.org/10.2147/OTT.S160685

Ejemplares similares